Computational study of the conformational preferences of the (R)

Journal of Peptide Science

Volumn 10, Issue 5, 2004, Pages 274-284

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO ACID; CARBON; CARBOXYLIC ACID DERIVATIVE; CYCLOPEPTIDE;

AB INITIO CALCULATION; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HYDROGEN BOND; MOLECULAR DYNAMICS; PARAMETRIC TEST; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; SYNTHESIS; THEORETICAL MODEL;

EID: 2342618736     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.526     Document Type: Article

References (32)

1. 1 Balaram P. Non‐standard amino acids in peptide design and protein engineering. Curr. Opin. Struct. Biol. 1992 ; 2: 845–851.
2. 2 Hanessian S, McNaughton‐Smith G, Lombart HG, Lubell WD. Design and synthesis of conformationally constrained amino acids as versatile scaffolds and peptide mimetics. Tetrahedron 1997 ; 53: 12 789–12 854.
3. 3 Cheng RP, Gellman SH, DeGrado WF. β‐Peptides: from structure to function. Chem. Rev. 2001 ; 101: 3219–3232.
4. 4 Rizo J, Gierasch LM. Constrained peptides: models of bioactive peptides and protein substructures. Annu. Rev. Biochem. 1992 ; 61: 387–418.
5. 5 Toniolo C, Crisma M, Formaggio F, Peggion C. Control of peptide conformation by the Thorpe‐Ingold effect (C alpha‐tetrasubstitution). Biopolymers (Pept. Sci.) 2001 ; 60: 396–419.
6. 6 Roesser JR, Chorghade MS, Hecht SM. Ribosome‐catalyzed formation of an abnormal peptide analogue. Biochemistry 1986 ; 25: 6361–6365.
7. 7 Wang L, Brock A, Herberich B, Schultz PG. Expanding the genetic code of Escherichia coli. Science 2001 ; 292: 498–500.
8. 8 Liu DR, Schultz PG. Progress toward the evolution of an organism with an expanded genetic code. Proc. Natl Acad. Sci. USA 1999 ; 96: 4780–4785.
9. 9 Griffin GW, Marchand AP. Synthesis and chemistry of cubanes. Chem. Rev. 1989 ; 89: 997–1010.
10. 10 Marchand AP. Synthesis and chemistry of homocubanes, biscubanes and trishomocubanes. Chem. Rev. 1989 ; 89: 1011–1033.
11. 11 Marchand AP. In Advances in Theoretically Interesting Molecules, Thummel RP (ed.). JAI Press: Greenwich, CT, 1989 ; 1: 357–399.
12. 12 Ranganathan D, Haridas V, Madhusudanan KP, Roy R, Nagaraj R, John GB, Sukhaswami MB. Design, synthesis and ion‐transport properties of a novel family of cyclic adamantane‐containing cystine peptides. Angew. Chem. Int. Ed. Engl. 1996 ; 35: 1105–1107.
13. 13 Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard J‐C, Poncelet M, Gueudet C, Heaulme M, Leyris R, Brouard A, Pelaprat D, Labbe‐Jullie C, Mazella J, Soubrie P, Maffrand J‐P, Rostene W, Kitabgi P, Le Fur G. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. Natl Acad. Sci. USA. 1993 ; 90: 65–69.
14. 14 Quere L, Longfils G, Boigegrain R, Labeeuw B, Gully D, Durant F. X‐Ray structural characterization of SR 142948, a novel potent synthetic neurotensin receptor antagonist. Bioorg. Med. Chem. Lett. 1998 ; 8: 653–658.
15. 15 Hong F, Zaidi J, Cusack B, Richelson E. Synthesis and biological studies of novel neurotensin(8–13) mimetics. Bioorg. Med. Chem. 2002 ; 10: 3849–3858.
16. 16 Brookes KB, Hickmott PW, Jutle KK, Schreyer CA. Introduction of pharmacophoric groups into polycyclic systems. Part 4. Aziridine, oxirane, and tertiary β‐hydroxyethylamine derivatives of adamantane. South Afr. J. Chem. 1992 ; 45: 8–11.
17. 17 Chacko KK, Zand R. Crystal and molecular structure of 2‐aminoadamantane‐2‐carboxylic acid hydrobromide. Acta Crystallogr. 1973 ; B29: 2681–2686.
18. 18 Nagasawa HT, Elberling JA, Shirota FN. Potential latentiation forms of biologically active compounds based on action of leucine‐aminopeptidase. Dipeptide derivatives of the tricycloaliphatic α‐amino acid adamantanine. J. Med. Chem. 1975 ; 18: 826–830.
19. 19 Kuroda Y, Ueda H, Nozawa H, Ogoshi H. Adamantyl amino acid as γ‐turn inducer for peptide. Tetrahedron Lett. 1997 ; 45: 7901–7904.
20. 20 Martins FJC, Viljoen AM, Kruger HG, Fourie L, Roscher J, Joubert JA, Wessels PL. Enantioselective Synthesis of Amino Acids from Pentacyclo[5.4.0.02,6.03,10.05,9]undecane‐8,11‐dione. Tetrahedron 2001 ; 57: 1601–1607.
21. 21 Gomez‐Catalan J, Perez JJ, Jimenez AI, Cativiela C. Study of the conformational profile of selected unnatural amino acid residues derived from L ‐phenylalanine. J. Peptide Sci. 1999 ; 5: 251–262.
22. 22 Gomez‐Catalan J, Jimenez AI, Cativiela C, Perez JJ. Study of the conformational profile of the cyclohexane analogs of L ‐phenylalanine. J. Peptide Res. 2001 ; 57: 435–446.
23. 23 Cordomí A, Gomez‐Catalan J, Jimenez AI, Cativiela C, Perez JJ. Study of the conformational profile of some phenylnorbornane amino acids. J. Peptide Sci. 2002 ; 8: 253–266.
24. 24 Aleman C, Jimenez AI, Cativiela C, Perez JJ, Casanovas J. Influence of the phenyl side chain on the conformation of cyclopropane analogues of phenylalanine. J. Phys. Chem. 2002 ; B106: 11 849–11 858.
25. 25 Gaussian 98, Revision A.3. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Zakrzewski VG, Montgomery JA, Jr., Stratmann RE, Burant JC, Dapprich S, Millam JM, Daniels AD, Kudin KN, Strain MC, Farkas O, Tomasi J, Barone V, Cossi M, Cammi R, Mennucci B, Pomelli C, Adamo C, Clifford S, Ochterski J, Petersson GA, Ayala PY, Cui Q, Morokuma K, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Cioslowski J, Ortiz JV, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Gomperts R, Martin RL, Fox DJ, Keith T, Al‐Laham MA, Peng CY, Nanayakkara A, Gonzalez C, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Andres JL, Head‐Gordon M, Replogle ES, Pople JA. Gaussian, Inc.: Pittsburgh, PA, 1998.
26. 26 Case DA, Pearlman DA, Caldwell JW, Cheatham TE III, Ross WS, Simmerling CL, Darden TA, Merz KM, Stanton RV, Cheng AL, Vincent JJ, Crowley M, Ferguson DM, Radmer RJ, Seibel GL, Singh UC, Weiner PK, Kollman PA. AMBER 5. University of California: San Francisco, 1997.
27. 27 Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G, Profeta S Jr, Weiner PJ. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc. 1984 ; 106: 765–784.
28. 28 Cornell WD, Cieplak P, Bayly CL, Gould IR, Merz KM, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA. A second generation force field for the simulation of proteins, nucleic acids and organic molecules. J. Am. Chem. Soc. 1995 ; 117: 5179–5197.
29. 29 Miertus S, Scrocco E, Tomasi J. Electrostatic interaction of a solute with a continuum. A direct utilization of ab initio molecular potentials for the prevision of solvent effects. Chem. Phys. 1981 ; 55: 117–129.
30. 30 Gomez‐Catalan J, Aleman C, Perez JJ. Conformational profile of 1‐amino cyclopropanecarboxylic acid. Theor. Chem. Acc. 2000 ; 103: 380–389.
31. 31 Scarsdale JN, Van Alsenoy C, Klimkowiski VJ, Schafer L, Momany FA. Ab initio studies of molecular geometries. 27. Optimized molecular structures and conformational analysis of N α ‐acetyl‐ N ′‐methylalanineamide and comparison with peptide crystal data and empirical calculations. J. Am. Chem. Soc. 1983 ; 105: 3438–3445.
32. 32 Shang HS, Head‐Gordon T. Stabilization of helices in glycine and alanine monopeptides in a reaction field model of solvent. J. Am. Chem. Soc. 1994 ; 116: 1528–1532.